image credit: Unsplash

EMA announces launch of two advice pilots to improve clinical trials in Europe

June 12, 2024


The pilots aim to improve the quality of applications for clinical trials and lay the foundation for the development of safe and effective medicines in Europe.

First launched in January 2022, the ACT EU initiative seeks to transform how clinical trials are initiated, designed and run.

The first pilot will offer medicinal product developers scientific advice on clinical trials and requirements for marketing authorisation applications (MAA) and will be assessed by the Scientist Advice Working Party and the Clinical Trials Coordination Group (CTCG).

Read More on PMLiVE